Drug Approval | November 19, 2022
Eugia Pharma receives USFDA approval for Amphotericin B Liposome for Injection
The product is expected to be launched by Q4 FY23.
The product is expected to be launched by Q4 FY23.
Value chain collaboration aims to foster a circular ecosystem and reduce the carbon footprint of single-use surgical instruments molded in Ixef PARA.
NULIBRY is a first-in-class cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A.
This new facility integrates multi-channel chip, micro-mixer system, and complex preparation system into a multi-channel micro-mixer core LNP manufacturing platform
In a rare occurrence worldwide, the CK Birla Hospital® treats 32-year-old woman for a giant mesenteric tumour via complex laparoscopic surgery
The facility is designed with advanced analytical equipment to provide testing services such as In-vitro Permeation testing
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
Marinus has broadened inclusion criteria in the RAISE trial to allow for enrollment of patients previously treated with IV anesthesia.
The company has launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price
Subscribe To Our Newsletter & Stay Updated
